Racura Oncology opens Korean recruitment for RC220 Phase 1 trial
Racura Oncology opened Korean recruitment for RC220, a Phase 1 solid tumours trial.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.